Expression of P-cadherin and N-cadherin in all invasive carcinomas in relation to clinicopathological features
| P-cadherin | N-cadherin | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Membrane | Cytoplasmic | ||||||||
| Neg | <50% | >50% | Neg | <50% | >50% | Neg | <50% | >50% | |
| EGFR, epidermal growth factor receptor; ER, oestrogen receptor; Neg, negative; PR, progesterone receptor. | |||||||||
| Size | |||||||||
| 0–20 mm | 26 | 5 | 3 | 21 | 2 | 8 | 23 | 6 | 2 |
| 21–50 mm | 50 | 11 | 5 | 42 | 8 | 16 | 47 | 11 | 8 |
| >50 mm | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 2 |
| Lymph node | |||||||||
| Positive | 39 | 10 | 5 | 35 | 7 | 12 | 40 | 9 | 5 |
| Negative | 36 | 6 | 3 | 28 | 4 | 13 | 29 | 9 | 7 |
| Grade | |||||||||
| I | 11 | 1 | 0 | 10 | 1 | 1 | 10 | 1 | 1 |
| II | 44 | 5 | 1 | 41 | 5 | 4 | 38 | 8 | 4 |
| III | 21 | 10 | 7 | 13 | 5 | 20 | 22 | 9 | 7 |
| ER | |||||||||
| Positive | 69 | 12 | 2 | 60 | 10 | 13 | 59 | 15 | 9 |
| Negative | 7 | 4 | 6 | 4 | 1 | 12 | 11 | 3 | 3 |
| PR | |||||||||
| Positive | 57 | 10 | 2 | 50 | 8 | 11 | 50 | 14 | 5 |
| Negative | 19 | 6 | 6 | 14 | 3 | 14 | 20 | 4 | 7 |
| EGFR | |||||||||
| Positive | 6 | 6 | 6 | 3 | 3 | 12 | 12 | 4 | 2 |
| Negative | 70 | 10 | 2 | 61 | 8 | 13 | 58 | 14 | 10 |